|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 31/138 | (2006.01) |
| A61K 31/4196 | (2006.01) | ||
| A61K 31/56 | (2006.01) | ||
| A61K 31/565 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| C07J 1/00 | (2006.01) |
| (11) | Number of the document | 1272195 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01917289.9 |
| Date of filing the European patent application | 2001-04-02 | |
| (97) | Date of publication of the European application | 2003-01-08 |
| (45) | Date of publication and mention of the grant of the patent | 2005-10-12 |
| (46) | Date of publication of the claims translation | 2006-01-25 |
| (86) | Number | PCT/GB2001/001500 |
| Date | 2001-04-02 |
| (87) | Number | WO 2001/074366 |
| Date | 2001-10-11 |
| (30) | Number | Date | Country code |
| 0008172 | 2000-04-05 | GB |
| (72) |
THURLIMANN, Beat, CH
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Fulvestranto panaudojimas rezistentiško krūties vėžio gydymui |
| USE OF FULVESTRANT IN THE TREATMENT OF RESISTANT BREAST CANCER |
| Payment date | Validity (years) | Amount | |
| 2020-03-23 | 20 | 347.00 EUR |